Search research articles
Contact Us
Filters
Showing results (91-100 of 162) with videos related to
Page
of 17
Sort By:
Kidney International Reports
|
June 9, 2025
Inducing <i>Oxalobacter formigenes</i> Colonization Reduces Urinary Oxalate in Healthy Adults
Sonia Fargue, Mangesh Suryavanshi, Kyle D Wood, et al.
Biomedicines
|
February 5, 2021
Novel Ex Vivo Model to Examine the Mechanism and Relationship of Esophageal Microbiota and Disease
Samuel Cass, Catherine Hamilton, Aaron Miller, et al.
Pharmacological Research
|
November 12, 2016
Novel indole-based compounds that differentiate alkylindole-sensitive receptors from cannabinoid receptors and microtubules: Characterization of their activity on glioma cell migration
Susan Fung, Cong Xu, Ernest Hamel, et al.
JAMA Neurology
|
October 13, 2015
Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis
Serena Ruggieri, Maria Petracca, Aaron Miller, et al.
Iscience
|
February 7, 2022
Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions
Zeynep Koşaloğlu-Yalçın, Jenny Lee, Jason Greenbaum, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 5, 2020
Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019)
Jan D Lünemann, Judit Diaz-Diaz, Bruno Stankoff, et al.
Neurology
|
February 19, 2016
The challenge of comorbidity in clinical trials for multiple sclerosis
Ruth Ann Marrie, Aaron Miller, Maria Pia Sormani, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
June 22, 2026
The Diagnostic Course of Sarcoidosis: A Population-Based Study Highlighting Risk Factors for a Delay in Diagnosis
Miles D Hagner, Aaron Miller, Solanus De la Serna, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 21, 2003
Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials
Filippo Martinelli Boneschi, Marco Rovaris, Kenneth P Johnson, et al.
Multiple Sclerosis and Related Disorders
|
October 15, 2019
Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study
Ilana Katz Sand, Emma K T Benn, Michelle Fabian, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 162) with videos related to
Sort By:
Page
of 17
Kidney International Reports
|
June 9, 2025
Inducing <i>Oxalobacter formigenes</i> Colonization Reduces Urinary Oxalate in Healthy Adults
Sonia Fargue, Mangesh Suryavanshi, Kyle D Wood, et al.
Biomedicines
|
February 5, 2021
Novel Ex Vivo Model to Examine the Mechanism and Relationship of Esophageal Microbiota and Disease
Samuel Cass, Catherine Hamilton, Aaron Miller, et al.
Pharmacological Research
|
November 12, 2016
Novel indole-based compounds that differentiate alkylindole-sensitive receptors from cannabinoid receptors and microtubules: Characterization of their activity on glioma cell migration
Susan Fung, Cong Xu, Ernest Hamel, et al.
JAMA Neurology
|
October 13, 2015
Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis
Serena Ruggieri, Maria Petracca, Aaron Miller, et al.
Iscience
|
February 7, 2022
Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions
Zeynep Koşaloğlu-Yalçın, Jenny Lee, Jason Greenbaum, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 5, 2020
Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019)
Jan D Lünemann, Judit Diaz-Diaz, Bruno Stankoff, et al.
Neurology
|
February 19, 2016
The challenge of comorbidity in clinical trials for multiple sclerosis
Ruth Ann Marrie, Aaron Miller, Maria Pia Sormani, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
June 22, 2026
The Diagnostic Course of Sarcoidosis: A Population-Based Study Highlighting Risk Factors for a Delay in Diagnosis
Miles D Hagner, Aaron Miller, Solanus De la Serna, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 21, 2003
Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials
Filippo Martinelli Boneschi, Marco Rovaris, Kenneth P Johnson, et al.
Multiple Sclerosis and Related Disorders
|
October 15, 2019
Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study
Ilana Katz Sand, Emma K T Benn, Michelle Fabian, et al.
Page
of 17